The WHO has sought “additional clarifications" from Bharat Biotech for Covaxin to conduct a final risk-benefit assessment for Emergency Use Listing of the vaccine.
from Top India News- News18.com https://ift.tt/3w26gfu
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment